Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emerald Health Therapeutics Inc (EMHTF)

Emerald Health Therapeutics Inc (EMHTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.9200 +1.04%
on 06/24/19
2.9000 -33.10%
on 05/30/19
-0.8780 (-31.16%)
since 05/24/19
3-Month
1.9200 +1.04%
on 06/24/19
3.4600 -43.93%
on 04/10/19
-1.1700 (-37.62%)
since 03/22/19
52-Week
1.4800 +31.08%
on 12/24/18
4.5000 -56.89%
on 09/11/18
-1.1770 (-37.76%)
since 06/22/18

Most Recent Stories

More News
Emerald Health Therapeutics Receives Cultivation License for New-Build Organic Cannabis Operation in British Columbia

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) has received its initial cultivation license from Health Canada for its new organic cannabis growing facility in Metro Vancouver,...

EMHTF : 1.9220 (-3.90%)
EMH.VN : 2.540 (-2.31%)
Latest Cannabis Companies to Reap the Benefits of Technology's Evolution

Technology has become prominent in almost every aspect of daily life for most consumers in the West. Even though technology has had a widespread impact, it continues to penetrate into other regions across...

BKKSF : 0.1958 (-2.73%)
HSTRF : 0.2628 (-1.54%)
EMHTF : 1.9220 (-3.90%)
SPRWF : 1.1700 (-1.19%)
BLIS.CN : 0.360 (unch)
EMH.VN : 2.540 (-2.31%)
FIRE.TO : 1.54 (-2.53%)
TRTC : 0.5750 (+2.68%)
TTT.VN : 0.310 (+6.90%)
NGTF : 0.4394 (+12.67%)
Cannabis Cultivators Aim to Meet the Vast Consumer Demand

With the "green rush" intensifying, cultivators are tasked with the challenge of meeting consumer demands. As such, cultivators around the world are building large scale facilities in order to produce...

EMHTF : 1.9220 (-3.90%)
MRMD : 2.2400 (+1.36%)
WDDMF : 1.0800 (-3.79%)
ACRGF : 19.5660 (+2.44%)
ACRG-U.CN : 19.560 (+1.09%)
Emerald Health Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 31, 2019 / Emerald Health Therapeutics, Inc. (TSXVENTURE: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 31, 2019 at...

EMHTF : 1.9220 (-3.90%)
Emerald Health Therapeutics Receives First Purchase Order to Supply its Cannabis Products to Quebec Recreational Cannabis Market

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) has received its first purchase order from Societe Quebecoise du Cannabis (SQDC) to supply its cannabis products to the Quebec recreational...

EMHTF : 1.9220 (-3.90%)
EMH.VN : 2.540 (-2.31%)
Cannabis Approval Ratings Just Increased in North America Again

The bullish momentum in cannabis stocks has continued in 2019. Related stocks have already exploded on news of Canadian legalization, U.S. states approving its medicinal or recreational use, and corporate...

EMHTF : 1.9220 (-3.90%)
SPRWF : 1.1700 (-1.19%)
WEED.TO : 53.36 (+0.15%)
LDSYF : 0.2787 (+0.18%)
LDS.CN : 0.370 (unch)
FIRE.TO : 1.54 (-2.53%)
EMH.VN : 2.540 (-2.31%)
TRST.TO : 6.80 (+1.19%)
CTST : 5.17 (+1.57%)
CGC : 40.52 (+0.90%)
Emerald Health Therapeutics Appoints Chief Operating Officer

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) has appointed Sean Rathbone as Chief Operating Officer. Mr. Rathbone brings expertise in operational leadership, corporate process...

EMHTF : 1.9220 (-3.90%)
EMH.VN : 2.540 (-2.31%)
Emerald Health Therapeutics Announces Pure Sunfarms' Receipt of Standard Processing License for Delta 3 Greenhouse Facility

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has...

EMHTF : 1.9220 (-3.90%)
EMH.VN : 2.540 (-2.31%)
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual...

KSHB : 4.5000 (+2.51%)
EMHTF : 1.9220 (-3.90%)
AXIM : 0.7850 (+3.29%)
CNPOF : 2.5000 (-5.30%)
OGRMF : 8.3500 (+4.64%)
OGI.VN : 8.320 (-2.69%)
EMBI : 0.2900 (-3.37%)
SRUTF : 0.4751 (-7.21%)
GSRX : 0.9500 (-5.00%)
SPRWF : 1.1700 (-1.19%)
SPR : 80.55 (-1.08%)
TGIF : N/A (unch)
TGIFF : 0.3350 (+1.52%)
MRMD : 2.2400 (+1.36%)
FIRE.TO : 1.54 (-2.53%)
EMH.VN : 2.540 (-2.31%)
ACRGF : 19.5660 (+2.44%)
Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) has shipped 6,000 40 ml units of its SYNC 25 CBD oil to the British Columbia Liquor Distribution Branch (BCLDB). The Emerald-branded...

EMHTF : 1.9220 (-3.90%)
EMH.VN : 2.540 (-2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade EMHTF with:

Key Turning Points

2nd Resistance Point 2.1533
1st Resistance Point 2.0767
Last Price 1.9220
1st Support Level 1.9367
2nd Support Level 1.8733

See More

52-Week High 4.5000
Fibonacci 61.8% 3.3464
Fibonacci 50% 2.9900
Fibonacci 38.2% 2.6336
Last Price 1.9220
52-Week Low 1.4800

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar